Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Market Movers
TipRanks 50 Index
AI Stocks
Largest Companies by Market Cap
ETFs
Top ETFs by Upside
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Ideas
Plans
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Trump Dashboard
New
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Economic Indicators
Inflation Rate
Unemployment Rate
Class Actions
Tools
Plans
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Screeners
Plans
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Dividends
Plans
My Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Experts
Plans
Portfolio
Plans
Trending News
More News >
News
Plans
Private Companies
Plans
Enterprise Solutions
Plans
Education
Personal Finance
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Advertise with Us
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
More
Plans
Plans
Plans
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Screeners
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Ideas
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Research Tools
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Calculators
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividends
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Experts
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
More
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Log Out
Advertisement
Advertisement
PTCT
Stock Latest News
The Fly
Controversial Prasad leaving FDA, NYT reports
23h ago
AZN
BMY
Premium
The Fly
Cantor downgrades uniQure to Neutral on FDA setback
7d ago
PTCT
QURE
Premium
Company Announcements
PTC Therapeutics Earnings Call Highlights Sephience Momentum
14d ago
PTCT
Premium
The Fly
PTC Therapeutics price target raised to $92 from $90 at Morgan Stanley
14d ago
PTCT
Premium
The Fly
PTC Therapeutics price target raised to $120 from $119 at Barclays
14d ago
PTCT
Premium
The Fly
PTC Therapeutics price target raised to $82 from $78 at RBC Capital
17d ago
PTCT
Premium
The Fly
PTC Therapeutics price target lowered to $93 from $97 at BofA
17d ago
PTCT
Premium
Ratings
Sephience-Led Growth, Global Expansion, and Robust Pipeline Underpin Buy Rating on PTC Therapeutics
17d ago
PTCT
Premium
The Fly
PTC Therapeutics price target lowered to $86 from $93 at Wells Fargo
17d ago
PTCT
Premium
Ratings
PTC Therapeutics: Sephience Uptake, Advancing Pipeline, and Strengthening Financials Support Buy Rating
17d ago
PTCT
Premium
Ratings
Balanced Outlook on PTC: Sephience-Driven Growth Offset by Duchenne Headwinds and Unmodeled Vatiquinone Upside Supports Hold Rating
18d ago
PTCT
Premium
Company Announcements
PTC Therapeutics Tops 2025 Revenue Guidance, Boosts Cash
18d ago
8K
PTCT
Premium
The Fly
PTC Therapeutics reports Q4 EPS ($1.67), consensus (41c)
18d ago
PTCT
Premium
The Fly
PTC Therapeutics sees 2026 product revenue up 19%-36%to $700M-$800M
18d ago
PTCT
Premium
Pre-Earnings
PTCT Earnings Report this Week: Is It a Buy, Ahead of Earnings?
20d ago
PTCT
Premium
The Fly
Closing Bell Movers: DraftKings down 15% after earnings miss
25d ago
ABNB
AMAT
Premium
Company Announcements
PTC Therapeutics Withdraws Translarna NDA After FDA Feedback
25d ago
8K
PTCT
Premium
The Fly
PTC Therapeutics price target raised to $97 from $96 at BofA
1M ago
PTCT
Premium
The Fly
PTC Therapeutics price target raised to $75 from $63 at TD Cowen
1M ago
PTCT
Premium
The Fly
PTC Therapeutics assumed with Overweight from Equal Weight at Barclays
1M ago
PTCT
Premium
Ratings
PTC Therapeutics: Sephience Outperformance and Votoplam De‑Risking Drive Upgraded Medium-Term Growth Outlook and Buy Rating
2M ago
PTCT
Premium
Company Announcements
PTC Therapeutics Posts Strong 2025 Results, Updates 2026 Outlook
2M ago
8K
PTCT
Show More
Trending
Indices
Stocks
ETFs
Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >
You need to enable JavaScript to run this app.
